Single Oral Dose of Bevenopran in Patients With Varying Degrees of Renal Impairment

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2013
The purpose of this study is to characterize the effect of renal function on the PK of a 0.25 mg single oral dose of bevenopran in humans and to assess the safety and tolerability of bevenopran in patients with varying degrees of renal impairment and in healthy subjects.
Epistemonikos ID: 9679e68234c492ec739b1e5a068557cb147a8440
First added on: May 12, 2024